Explore how MDMA affects the brain and how this therapy has exciting potential for mental health treatment, specifically PTSD.


MDMA-assisted therapy has received a Breakthrough Therapy designation by the FDA for the treatment of PTSD. In this webinar, Dr. Allison Feduccia explores how MDMA works in the brain, the therapeutic method used in research, and findings from the clinical trials. MDMA could become a FDA-approved medication within the next year. This is an exciting prospect for what is on the horizon in terms of new mental health treatments.


Enroll & Watch Now

Instructor(s)

Allison Feduccia, PhD

I’m an educator and advocate for the responsible use of psychedelic medicines. By creating points of connection for psychedelic researchers, therapists and patients, my projects act as a zip-tie for humans in the proliferating field of psychedelics. As a professional in this growing field, I recognize the need for more education, trusted resources, and access to psychedelic therapies. Rising to meet these needs in our community, I co-founded Psychedelic Support in 2018. Prior to this, I began researching MDMA in 2004 and have worked on studies of psychedelics and mental health conditions at UT Austin, UCSF, NIH, and MAPS PBC.